RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients

Overview of attention for article published in Oncotarget, May 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 1 news story.

Although chemotherapy remains the benchmark for drug development in pancreatic cancer, signals seen with selective KRAS -targeted…